Pulmonary Atresia Treatments

Find Pulmonary Atresia Treatments

Generic Name

Alprostadil

Brand Names

Caverject, Edex, Prostin

FDA approval date: October 16, 1981

Classification: Prostaglandin Analog

Form: Injection

What is Caverject (Alprostadil)?

CAVERJECT IMPULSE is a prostaglandin E1 agonist indicated For the treatment of erectile dysfunction.

Approved To Treat

Top Global Experts

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

Pilot Study of a Wearable EEG Headband as a Meditation Device for Breast Cancer Survivors

Enrollment Status: Recruiting

Publish Date: June 02, 2026

Intervention Type: Procedure, Other

Study Phase: Early Phase 1

Summary: This early phase I trial evaluates the feasibility and impact of a meditation headband system (MUSE-S) for breast cancer survivors. Anxiety and insomnia are among the most common distresses in breast cancer survivors during and after chemotherapy, in part due to the side effects of chemotherapy, fear of cancer coming back, progression of the cancer, and uncertainty of the future. These distresses ...

PRIMULA Preg (Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users): The AstraZeneca Pregnancy Study for Anifrolumab

Enrollment Status: Recruiting

Publish Date: May 26, 2026

Intervention Type: Drug

Summary: PRIMULA Preg (Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users) is a prospective, observational cohort study designed to evaluate the association between anifrolumab exposure during pregnancy and subsequent adverse maternal, fetal, and infant outcomes. This study will fulfil an FDA post-marketing requirement.

Pregnancy and Infant Outcomes in Anifrolumab Exposed Pregnancies Using PRegnancy Outcomes Intensive Monitoring (PRIM) Data: The Anifrolumab PRIM Program

Enrollment Status: Recruiting

Publish Date: May 22, 2026

Intervention Type: Drug

Summary: Pregnancy and infant outcomes in anifrolumab exposed pregnancies using PRegnancy outcomes Intensive Monitoring (PRIM) data: The anifrolumab PRIM program

View All Clinical Trials